Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42])
The summary for the Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42]) Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
| Federal Grant Title: | PHASE II SMALL BUSINESS TECHNOLOGY TRANSFER RENEWAL AWARDS FOR DEVICE ASSESSMENT OR PRECLINICAL STUDIES (STTR [R42]) |
| Federal Agency Name: | National Institutes of Health |
| Program Name: | Child Health and Human Development Extramural Research |
| Grant Categories: | Health Income Security and Social Services |
| CFDA Number: | 93.865 |
| Funding Opportunity Number: | PA-06-029 |
| Posted Date: | Oct 21, 2005 |
| Creation Date: | Oct 21, 2005 |
| Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announcement for details. |
| Current Application Deadline: | Information not provided |
| Archive Date: | Apr 14, 2006 |
| Total Program Funding: | Information not provided |
| Maximum Federal Grant Award: | Information not provided |
| Minimum Federal Grant Award: | Information not provided |
| Expected Number of Awards: | Information not provided |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Only United States small business concerns (SBCs) are eligible to submit STTR applications. A small business concern is one that, at the time of award for both Phase I and Phase II awards, meets all of the following criteria: - Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. - Is at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. - Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's (SBA) Government Contracting Area Office or Office of Size Standards.
- Grant Description
- - The purpose of this Funding Opportunity Announcement (FOA) is to solicit from NICHD-supported STTR Phase II awardees, competing continuation applications that propose to continue the process of assessing and improving devices or conducting preclinical studies of drugs or devices that ultimately require: 1) clinical evaluation, 2) approval of a Federal regulatory agency, and 3) continuing refinements to durable medical equipment (DME) designs such as cost reduction, testing for safety, durability, and reliability, and meeting or establishing standards. Such products include, but are not limited to, devices, drugs, vaccines, medical implants, etc. related to the mission of the NICHD. - Awards in response to this solicitation are expected to average in the range of $150,000 to $300,000 total costs per year for up to three years. - The anticipated number of awards will depend upon the scientific/technical merit of applications received and the availability of funds. - This FOA will utilize the Phase II Small Business Technology Transfer (STTR [R42]) grant mechanism and runs in parallel with a FOA of identical scientific intent, PA-06-030, that solicits applications under the Phase II Small Business Technology Transfer Research program (STTR [R42]) grant mechanisms.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PA-06-029.html http://grants.nih.gov/grants/guide/pa-files/PA-06-029.html
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Pediatric Critical Care and Trauma Scientist Development Program (K12)
- • Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associ...
- • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...
- • Male Contraceptive Development Program (U01)
- • Orthotics for Healthy Development (STTR) (R41)
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- • Developmental Mechanisms of Human Structural Birth Defects
- More Grants from the National Institutes of Health
- • Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...
- • Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...
- • Pediatric Critical Care and Trauma Scientist Development Program (K12)
- • Evidence-based Demonstration Projects in Immunization (Admin Supp)
- • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...
